FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2624883664> ?p ?o ?g. }

• W2624883664 endingPage "2214" @default.
• W2624883664 startingPage "2201" @default.
• W2624883664 abstract "Abstract The use of light as a means of therapy for bladder cancer has a long history but has been hampered by a lack of tumor specificity and therefore, damage to the normal bladder mucosa. Here, we describe a targeted form of phototherapy called photoimmunotherapy (PIT), which targets EGFR-expressing bladder cancer. Anti-EGFR antibody panitumumab was labeled with the photoabsorber (PA), IRDye 700Dx (IR700), to create a panitumumab-IR700 antibody–PA conjugate that is activated by near-infrared radiation (NIR). Bladder cancer tissue microarray (TMA) and bladder cancer cell lines were analyzed for expression of EGFR. Mechanism of PIT-induced cell death was studied using proliferation assays, transmission electron microscopy (TEM), and production of reactive oxygen species. Finally, the in vivo effect was studied in xenografts. EGFR staining of TMAs showed that while most bladder cancers have expression of EGFR to a varying degree, squamous cell carcinomas (SCC) have the highest expression of EGFR. Panitumumab-IR700 activated by NIR light rapidly killed UMUC-5 cells, a bladder SCC line. Panitumumab alone, panitumumab-IR700 without NIR, or NIR alone had no effect on cells. TEM demonstrated that cell death is due to necrosis. Singlet oxygen species contributed toward cell death. NIR-PIT with panitumumab-IR700 reduced growth compared with only panitumumab-IR700–treated UMUC-5 xenograft tumors. PIT is a new targeted treatment for bladder cancer. Panitumumab-IR700–induced PIT selectively kills EGFR-expressing bladder cancer cells in vitro and in vivo and therefore warrants further therapeutic studies in orthotopic xenografts of bladder cancer and ultimately in patients. Mol Cancer Ther; 16(10); 2201–14. ©2017 AACR." @default.
• W2624883664 created "2017-06-23" @default.
• W2624883664 creator A5014568767 @default.
• W2624883664 creator A5015643693 @default.
• W2624883664 creator A5019566512 @default.
• W2624883664 creator A5024184100 @default.
• W2624883664 creator A5038598676 @default.
• W2624883664 creator A5052291553 @default.
• W2624883664 creator A5056148509 @default.
• W2624883664 creator A5082080836 @default.
• W2624883664 creator A5084514632 @default.
• W2624883664 creator A5084627594 @default.
• W2624883664 creator A5090173640 @default.
• W2624883664 date "2017-10-01" @default.
• W2624883664 modified "2023-09-27" @default.
• W2624883664 title "Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer" @default.
• W2624883664 cites W1497159330 @default.
• W2624883664 cites W1499045271 @default.
• W2624883664 cites W1546210634 @default.
• W2624883664 cites W1593917422 @default.
• W2624883664 cites W1625968974 @default.
• W2624883664 cites W172279490 @default.
• W2624883664 cites W1930879408 @default.
• W2624883664 cites W1966197345 @default.
• W2624883664 cites W1978846041 @default.
• W2624883664 cites W1983692618 @default.
• W2624883664 cites W1988361384 @default.
• W2624883664 cites W2000380259 @default.
• W2624883664 cites W2003992985 @default.
• W2624883664 cites W2004003818 @default.
• W2624883664 cites W2015816208 @default.
• W2624883664 cites W2017606460 @default.
• W2624883664 cites W2018385435 @default.
• W2624883664 cites W2024539541 @default.
• W2624883664 cites W2025553797 @default.
• W2624883664 cites W2034462044 @default.
• W2624883664 cites W2042633133 @default.
• W2624883664 cites W2062273647 @default.
• W2624883664 cites W2067964015 @default.
• W2624883664 cites W2068523052 @default.
• W2624883664 cites W2072225623 @default.
• W2624883664 cites W2083703739 @default.
• W2624883664 cites W2094337052 @default.
• W2624883664 cites W2113156769 @default.
• W2624883664 cites W2118341617 @default.
• W2624883664 cites W2118590426 @default.
• W2624883664 cites W2140706655 @default.
• W2624883664 cites W2163941629 @default.
• W2624883664 cites W2235523093 @default.
• W2624883664 cites W2413703360 @default.
• W2624883664 cites W2414744424 @default.
• W2624883664 cites W2431862749 @default.
• W2624883664 cites W4211024586 @default.
• W2624883664 cites W4321000884 @default.
• W2624883664 doi "https://doi.org/10.1158/1535-7163.mct-16-0924" @default.
• W2624883664 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5628127" @default.
• W2624883664 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28619755" @default.
• W2624883664 hasPublicationYear "2017" @default.
• W2624883664 type Work @default.
• W2624883664 sameAs 2624883664 @default.
• W2624883664 citedByCount "57" @default.
• W2624883664 countsByYear W26248836642017 @default.
• W2624883664 countsByYear W26248836642018 @default.
• W2624883664 countsByYear W26248836642019 @default.
• W2624883664 countsByYear W26248836642020 @default.
• W2624883664 countsByYear W26248836642021 @default.
• W2624883664 countsByYear W26248836642022 @default.
• W2624883664 countsByYear W26248836642023 @default.
• W2624883664 crossrefType "journal-article" @default.
• W2624883664 hasAuthorship W2624883664A5014568767 @default.
• W2624883664 hasAuthorship W2624883664A5015643693 @default.
• W2624883664 hasAuthorship W2624883664A5019566512 @default.
• W2624883664 hasAuthorship W2624883664A5024184100 @default.
• W2624883664 hasAuthorship W2624883664A5038598676 @default.
• W2624883664 hasAuthorship W2624883664A5052291553 @default.
• W2624883664 hasAuthorship W2624883664A5056148509 @default.
• W2624883664 hasAuthorship W2624883664A5082080836 @default.
• W2624883664 hasAuthorship W2624883664A5084514632 @default.
• W2624883664 hasAuthorship W2624883664A5084627594 @default.
• W2624883664 hasAuthorship W2624883664A5090173640 @default.
• W2624883664 hasBestOaLocation W26248836641 @default.
• W2624883664 hasConcept C121608353 @default.
• W2624883664 hasConcept C126322002 @default.
• W2624883664 hasConcept C142724271 @default.
• W2624883664 hasConcept C150903083 @default.
• W2624883664 hasConcept C207001950 @default.
• W2624883664 hasConcept C2778332735 @default.
• W2624883664 hasConcept C2779438470 @default.
• W2624883664 hasConcept C2779998722 @default.
• W2624883664 hasConcept C2780352672 @default.
• W2624883664 hasConcept C502942594 @default.
• W2624883664 hasConcept C526805850 @default.
• W2624883664 hasConcept C71924100 @default.
• W2624883664 hasConcept C86803240 @default.
• W2624883664 hasConceptScore W2624883664C121608353 @default.
• W2624883664 hasConceptScore W2624883664C126322002 @default.
• W2624883664 hasConceptScore W2624883664C142724271 @default.
• W2624883664 hasConceptScore W2624883664C150903083 @default.

• next